These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 25008452)
21. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer. Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863 [TBL] [Abstract][Full Text] [Related]
22. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Bednarz-Knoll N; Alix-Panabières C; Pantel K Cancer Metastasis Rev; 2012 Dec; 31(3-4):673-87. PubMed ID: 22733306 [TBL] [Abstract][Full Text] [Related]
23. Detection of FAM172A expressed in circulating tumor cells is a feasible method to predict high-risk subgroups of colorectal cancer. Cui CH; Chen RH; Zhai DY; Xie L; Qi J; Yu JL Tumour Biol; 2017 Jun; 39(6):1010428317699126. PubMed ID: 28618931 [TBL] [Abstract][Full Text] [Related]
24. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer. Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076 [TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cells in lung cancer. Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441 [TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168 [TBL] [Abstract][Full Text] [Related]
28. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells. Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746 [TBL] [Abstract][Full Text] [Related]
29. Circulating tumour cells: insights into tumour heterogeneity. Hayes DF; Paoletti C J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916 [TBL] [Abstract][Full Text] [Related]
30. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases. Giesing M; Driesel G; Molitor D; Suchy B BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102 [TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072 [TBL] [Abstract][Full Text] [Related]
32. Breast cancer circulating tumor cells with mesenchymal features-an unreachable target? Topa J; Grešner P; Żaczek AJ; Markiewicz A Cell Mol Life Sci; 2022 Jan; 79(2):81. PubMed ID: 35048186 [TBL] [Abstract][Full Text] [Related]
33. Circulating Tumor Cell Phenotype Detection and Epithelial-Mesenchymal Transition Tracking Based on Dual Biomarker Co-Recognition in an Integrated PDMS Chip. Xu H; Zuo Y; Gao S; Liu Y; Liu T; He S; Wang M; Hu L; Li C; Yu Y Small; 2024 Sep; 20(36):e2310360. PubMed ID: 38698606 [TBL] [Abstract][Full Text] [Related]
34. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556 [TBL] [Abstract][Full Text] [Related]
35. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients. Carneiro A; Piairo P; Teixeira A; Ferreira D; Cotton S; Rodrigues C; Chícharo A; Abalde-Cela S; Santos LL; Lima L; Diéguez L Cells; 2022 Jan; 11(3):. PubMed ID: 35159186 [TBL] [Abstract][Full Text] [Related]
36. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. Bhangu A; Wood G; Mirnezami A; Darzi A; Tekkis P; Goldin R Surg Oncol; 2012 Dec; 21(4):316-23. PubMed ID: 22981546 [TBL] [Abstract][Full Text] [Related]
38. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology. Ma YC; Wang L; Yu FL Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577 [TBL] [Abstract][Full Text] [Related]
39. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications. Danova M; Torchio M; Mazzini G Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456 [TBL] [Abstract][Full Text] [Related]
40. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Lecharpentier A; Vielh P; Perez-Moreno P; Planchard D; Soria JC; Farace F Br J Cancer; 2011 Oct; 105(9):1338-41. PubMed ID: 21970878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]